In a collaborative effort by cancer specialists and chemists, researchers from the University of Chicago, the University of North Carolina at Chapel Hill, Peking University, and Tsinghua University have formulated an advanced type of nanoparticle that carries a compound derived from bacteria to target a potent immune system pathway. The nanoparticles disrupt a tumor’s blood vessel structure and stimulate an immune response. This approach also helps overcome resistance to immunotherapy treatments in certain pancreatic tumors and boosts response to radiation therapy in gliomas (tumors that occur in the brain and spinal cord).
An official website of the United States government.